Balyasny Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-248,038
Closed -$8.15M 1968
2024
Q4
$8.15M Buy
+248,038
New +$8.15M 0.01% 723
2024
Q3
Sell
-41,793
Closed -$1.8M 1917
2024
Q2
$1.8M Sell
41,793
-36,695
-47% -$1.58M ﹤0.01% 1080
2024
Q1
$2.29M Buy
78,488
+36,485
+87% +$1.07M ﹤0.01% 1059
2023
Q4
$935K Sell
42,003
-223,034
-84% -$4.97M ﹤0.01% 1234
2023
Q3
$6.56M Buy
265,037
+46,937
+22% +$1.16M 0.01% 716
2023
Q2
$6.18M Sell
218,100
-102,907
-32% -$2.91M 0.01% 723
2023
Q1
$7.37M Buy
321,007
+41,450
+15% +$952K 0.02% 689
2022
Q4
$7.85M Buy
+279,557
New +$7.85M 0.02% 631
2020
Q4
Sell
-89,988
Closed -$3.15M 1117
2020
Q3
$3.15M Buy
+89,988
New +$3.15M 0.02% 572
2019
Q2
Sell
-4,273
Closed -$288K 1301
2019
Q1
$288K Sell
4,273
-81,003
-95% -$5.46M ﹤0.01% 1208
2018
Q4
$3.93M Sell
85,276
-266,721
-76% -$12.3M 0.03% 486
2018
Q3
$27.1M Sell
351,997
-54,955
-14% -$4.24M 0.12% 205
2018
Q2
$34.3M Sell
406,952
-276,412
-40% -$23.3M 0.16% 158
2018
Q1
$55.9M Sell
683,364
-446,899
-40% -$36.5M 0.23% 95
2017
Q4
$64.6M Buy
1,130,263
+164,111
+17% +$9.38M 0.2% 115
2017
Q3
$64.5M Buy
966,152
+13,900
+1% +$928K 0.25% 87
2017
Q2
$49M Buy
952,252
+83,130
+10% +$4.28M 0.2% 115
2017
Q1
$50.8M Buy
869,122
+184,040
+27% +$10.7M 0.24% 100
2016
Q4
$28.6M Sell
685,082
-235,622
-26% -$9.83M 0.15% 163
2016
Q3
$48.6M Buy
920,704
+595,134
+183% +$31.4M 0.28% 111
2016
Q2
$13.6M Buy
325,570
+227,120
+231% +$9.52M 0.09% 251
2016
Q1
$4M Buy
98,450
+10,950
+13% +$445K 0.02% 450
2015
Q4
$5.68M Sell
87,500
-38,661
-31% -$2.51M 0.04% 422
2015
Q3
$8.91M Buy
+126,161
New +$8.91M 0.07% 323